secwatch.observer — SEC 8-K summary
======================================

Issuer:     GYRE THERAPEUTICS, INC. (GYRE)
CIK:        0001124105
Form:       8-K
Filed at:   2025-01-06T23:59:59+00:00
Accession:  0001140361-25-000292
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Gyre Therapeutics chairman Ying Luo resigns; Ping Zhang appointed as lead independent director
--------------------------------------------------------------------------------

- Ying Luo resigned as Chairman and Board member (eff. Dec 31, 2024) to focus on other responsibilities at GNI Group Ltd.
- Ping Zhang appointed Class I director, lead independent director, and Nominating Committee member (eff. Jan 5, 2025).
- Songjiang Ma appointed Chairman of Gyre Pharmaceuticals Board (eff. Jan 6, 2025).
- Zhang is Managing Partner of String Capital and serves on the boards of GNI and Asian Star Co.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1124105/000114036125000292/0001140361-25-000292-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1124105/000114036125000292/ef20041130_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-000292

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer